A detailed history of Macquarie Group LTD transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Macquarie Group LTD holds 211,755 shares of IART stock, worth $3.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
211,755
Previous 723,088 70.72%
Holding current value
$3.78 Million
Previous $25.6 Million 75.93%
% of portfolio
0.01%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$23.14 - $34.72 $11.8 Million - $17.8 Million
-511,333 Reduced 70.72%
211,755 $6.17 Million
Q1 2024

May 14, 2024

SELL
$33.4 - $45.2 $5.56 Million - $7.52 Million
-166,341 Reduced 18.7%
723,088 $25.6 Million
Q4 2023

Feb 14, 2024

SELL
$34.21 - $44.59 $19.7 Million - $25.7 Million
-575,696 Reduced 39.29%
889,429 $38.7 Million
Q3 2023

Nov 14, 2023

SELL
$37.8 - $45.97 $7.23 Million - $8.79 Million
-191,181 Reduced 11.54%
1,465,125 $56 Million
Q2 2023

Aug 14, 2023

SELL
$37.95 - $58.98 $2.12 Million - $3.3 Million
-55,913 Reduced 3.27%
1,656,306 $68.1 Million
Q1 2023

May 15, 2023

BUY
$52.61 - $60.49 $276,518 - $317,935
5,256 Added 0.31%
1,712,219 $98.3 Million
Q4 2022

Feb 21, 2023

SELL
$42.17 - $58.6 $2.24 Million - $3.11 Million
-53,033 Reduced 3.01%
1,706,963 $95.7 Million
Q3 2022

Nov 14, 2022

BUY
$42.28 - $57.17 $15.5 Million - $21 Million
366,545 Added 26.3%
1,759,996 $74.6 Million
Q2 2022

Aug 15, 2022

BUY
$53.86 - $66.52 $507,899 - $627,283
9,430 Added 0.68%
1,393,451 $75.3 Million
Q1 2022

May 16, 2022

BUY
$62.86 - $69.24 $142,315 - $156,759
2,264 Added 0.16%
1,384,021 $88.9 Million
Q4 2021

Feb 11, 2022

SELL
$62.47 - $73.25 $1.59 Million - $1.87 Million
-25,518 Reduced 1.81%
1,381,757 $92.6 Million
Q3 2021

Nov 12, 2021

BUY
$64.97 - $76.19 $349,668 - $410,054
5,382 Added 0.38%
1,407,275 $96.4 Million
Q2 2021

Aug 13, 2021

BUY
$66.79 - $76.63 $10.7 Million - $12.3 Million
160,517 Added 12.93%
1,401,893 $95.7 Million
Q1 2021

May 14, 2021

SELL
$62.63 - $71.15 $2 Million - $2.28 Million
-31,980 Reduced 2.51%
1,241,376 $85.8 Million
Q4 2020

Feb 16, 2021

BUY
$43.31 - $66.55 $6.79 Million - $10.4 Million
156,838 Added 14.05%
1,273,356 $82.7 Million
Q3 2020

Nov 13, 2020

BUY
$43.33 - $51.72 $20.7 Million - $24.7 Million
477,890 Added 74.83%
1,116,518 $52.7 Million
Q2 2020

Aug 11, 2020

BUY
$41.42 - $55.57 $24.3 Million - $32.6 Million
585,936 Added 1112.0%
638,628 $30 Million
Q1 2020

May 15, 2020

BUY
$36.67 - $61.04 $67,729 - $112,740
1,847 Added 3.63%
52,692 $2.35 Million
Q4 2019

Feb 14, 2020

BUY
$55.73 - $62.49 $338,559 - $379,626
6,075 Added 13.57%
50,845 $2.96 Million
Q3 2019

Nov 14, 2019

BUY
$53.29 - $64.59 $2.39 Million - $2.89 Million
44,770 New
44,770 $2.69 Million
Q2 2018

Aug 14, 2018

SELL
$54.05 - $67.23 $2.21 Million - $2.74 Million
-40,805 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$46.55 - $57.38 $1.9 Million - $2.34 Million
40,805 New
40,805 $2.26 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.49B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.